Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9325260 | 0.89 | CA2 (0.78) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL13445252 | 0.88 | ALDH1A1 (0.77) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL41372 | 0.86 | ALDH1A1 (0.82) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL6393111 | 0.86 | ALDH1A1 (0.74) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL5799550 | 0.84 | ALDH1A1 (0.71) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL15899119 | 0.84 | ALDH1A1 (0.71) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL4846711 | 0.82 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL1820762 | 0.82 | ALDH1A1 (1.00) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL10792219 | 0.82 | CA2 (0.69) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 | |
| SCHEMBL1582969 | 0.82 | ALDH1A1 (0.91) | ALDH1A1CYP3A4CYP2C9CYP2C19CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118428544-A | Method and related device for predicting periodic multi-node power load | 广东电网有限责任公司广州供电局 | 2024-08-02 | — | — | CN | claimed |
| CN-115174470-B | Logic router | NICIRA股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-114222800-B | Isocyanate adhesive | SIKA技术股份公司 | 2024-03-08 | — | — | CN | claimed |
| CN-111989230-B | Pneumatic tire | 横滨橡胶株式会社 | 2023-03-28 | — | — | CN | claimed |
| EP-3716553-B1 | INTERMEDIATE LOGICAL INTERFACES IN A VIRTUAL DISTRIBUTED ROUTER ENVIRONMENT | NICIRA INC (US) | 2022-10-05 | — | — | EP | claimed |
| CN-114251789-A | Control method and device for improving operation energy efficiency of multi-split heating mode and multi-split air conditioner | 宁波奥克斯电气股份有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-102388014-A | Synthesis method of chiral alpha-aryl propionic acid derivative | DSM IP ASSETS BV | 2012-03-21 | — | — | CN | claimed |
| US-20120029226-A1 | METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES | DSM IP ASSETS B.V. (NL) | 2012-02-02 | — | — | US | claimed |
| EP-2393771-A1 | Method for the synthesis of chiral alpha-aryl propionic acid derivatives | DSM IP Assets B.V. (NL) | 2011-12-14 | — | — | EP | claimed |
| WO-2010089343-A1 | METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES | DSM IP ASSETS B.V. (NL) | 2010-08-12 | — | — | WO | claimed |
| EP-0839056-B1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT INC (US) | 2003-05-07 | — | — | EP | claimed |
| EP-0886634-B1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT INC (US) | 2002-04-24 | — | — | EP | claimed |
| EP-0839056-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-09-13 | — | — | EP | claimed |
| EP-0886634-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-08-02 | — | — | EP | claimed |
| EP-0886634-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | claimed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | claimed |
| US-5648536-A | Process for producing ioversol | LAFAYETTE PHARMACEUTICALS LLC | 1997-07-15 | — | — | US | claimed |
| WO-1996040286-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| US-4699634-A | SEMIPERMEABLE MEMBRANES | THE STANDARD OIL COMPANY (US) | 1987-10-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029226-A1 | METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES | GRIA1, GRIA3, GRIA2 | ALDH1A1 101/4885CYP3A4 246/4885CYP2C9 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.